How much does Doptelet (Avatrombopag Maleate Tablets) Cost& price without insurance in China?
Doptelet® is the commercial brand name of Avatrombopag Maleate Tablets, an orally active thrombopoietin receptor agonist developed by Dova Pharmaceuticals. It binds to thrombopoietin receptor on megakaryocytes to stimulate bone marrow megakaryocyte proliferation and differentiation, thereby raising peripheral blood platelet count.
Main Indications
Treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) inadequately responsive to prior therapy;
Perioperative platelet elevation for adult patients with chronic liver disease‑related thrombocytopenia before invasive procedures.
Common Side Effects
Common mild adverse reactions: Headache, fatigue, nausea, diarrhea and upper respiratory tract infection.
Laboratory abnormalities: Rare transient elevation of hepatic enzymes.
Severe but manageable risks: Thromboembolic events and hypersensitivity reactions.
Approval Status in China
Doptelet® (Avatrombopag Maleate Tablets, 20mg, domestic Chinese brand name: Sukexin) was officially approved for marketing in China in 2020. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Doptelet (Avatrombopag Maleate Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
